HDAC6 and lung carcinoma: Scriptaid targets HDAC1, 2, and 8, and HDAC6 of Class IIb and has been developed as a potent HDACi with anti-tumour activity against several cancers such as endometrial, ovarian, colon or lung cancer [32,40].